Welcome to the e-CCO Library!

P643: Generalizability of Crohn’s disease randomized controlled trials compared to clinical practice
Year: 2022
Source: ECCO'22
Authors: Chhibba, T.(1);Frolkis, A.(2);Ma, C.(2);
Created: Friday, 11 February 2022, 3:56 PM
P643: Patient perspectives and expectations in inflammatory bowel disease: a systematic review
Year: 2021
Source: ECCO'21 Virtual
Authors: Balram, B.(1);Al Khoury, A.(2);Bessissow, T.(3);Afif, W.(3);Gonczi, L.(4);Abreu, M.(2);Lakatos, P.L.(3,4);
Created: Wednesday, 2 June 2021, 4:12 PM
P643: Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sanz Segura, P.(1)*;Gomollón, F.(2);García García, S.(3);Vela, M.(4);Fernández-Clotet, A.(5);Muñoz, R.(6);García de la Filia, I.(7);García Prada, M.(8);Ferrer Rosique, J.A.(9);García, M.J.(10);de Francisco, R.(11);Arias, L.(12);Barrio, J.(13);Guerra, I.(14);Ponferrada Diaz, A.(15);P. Gisbert, J.(16);Carrillo-Palau, M.(17);Calvet, X.(18);Márquez-Mosquera, L.(19);Gros, B.(20);Cañete, F.(21);Monfort, D.(22);Madrigal, R.E.(23);Roncero, O.(24);Laredo, V.(2);Montoro, M.(25);Muñoz, C.(26);López-Cauce, B.(27);Lorente, R.(28);Fuentes, A.(29);Vega, P.(30);Martín, D.(31);Nerín de la Puerta, J.(1);Varela, P.(32);Casas-Deza, D.(33);Martínez, P.(34);Pajares, R.(35);J. Lucendo, A.(36);Domènech, E.(21);García-López, S.(33);
Created: Friday, 14 July 2023, 11:12 AM
P643: Therapeutic thresholds for infliximab trough levels during maintenance treatment in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rasmussen M.*1, Brynskov J.1, Ainsworth M.A.1, Buhl S.1, Bendtzen K.2, Steenholdt C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P644 Post-operative Crohn’s disease recurrence in Glasgow: How common is it and does deprivation matter?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Brownson1, S. Shields1, M.H. Derakhshan1, J. Macdonald1, G. Nicholson2, J.P. Seenan1

Created: Thursday, 30 January 2020, 10:12 AM
P644: Effectiveness of vedolizumab on intestinal outcomes and articular manifestations: Real-world data from the Sicilian Network for inflammatory bowel disease (SN-IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

F.S. Macaluso1*, R. Orlando1, W. Fries2, M. Scolaro2, A. Magnano3, D. Pluchino3, M. Cappello4, G.C. Morreale4, S. Siringo5, A.C. Privitera6, C. Ferracane6, N. Belluardo7, N. Alberghina7, M. Ventimiglia1, G. Rizzuto1, S. Renna1, M. Cottone1, A. Orlando1, Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Created: Thursday, 21 February 2019, 9:14 AM
P644: Factors and salvage surgery for treatment of pouch failure after restorative proctocolectomy for ulcerative colitis – a single-institution study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kuroki H., Sugita A., Koganei K., Tatsumi K., Futatsuki R., Obara N.

Created: Wednesday, 20 February 2019, 10:36 AM
P644: Hospitalization and abdominal surgery rates in CD according to drug-dispensing: a temporal trend analysis from the Brazilian public healthcare national system
Year: 2021
Source: ECCO'21 Virtual
Authors: Magro, D.O.(1);Kotze, P.G.(2);Quaresma, A.B.(3);Damiao, A.O.M.C.(4);Valverde, D.A.(5);Panaccione, R.(6);Coward, S.(7);Ng, S.C.(8);Kaplan, G.G.(7);Coy, C.S.R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P644: Impact of Postoperative Treatment with Immunomodulators and Anti-TNFα agents on long-term Reoperation Rate in ileocaecal Crohn’s Disease.
Year: 2022
Source: ECCO'22
Authors: AratariPhD, A.(1);Scribano, M.L.(2);Baccolini, V.(3);Pugliese, D.(4);De Biasio, F.(1);Verna, S.(2);Morretta, C.(4);Armuzzi, A.(4);Festa, S.(1);Papi, C.(1);
Created: Friday, 11 February 2022, 3:56 PM
P644: Leucine-rich alpha 2 glycoprotein- A useful biomarker to discriminate small intestinal mucosal healing in asymptomatic CRP-negative Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tanaka, A.(1)*;Kanmura, S.(1);Maeda, N.(1);Kuwazuru, K.(1);Komaki, F.(1);Komaki, Y.(1);Ido, A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P644: Mindfulness-based stress reduction in adult patients with active Crohn's disease: preliminary findings based on the subjective units of distress scale: an IIRN study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Schwartz*1, G. Goren2, P. Perpinial2, M. Friger3, O. Sarid2, V. Slonim-Nevo2, R. Sergienko3, A. Nemirovsky4, E. Vinogradov4, D. Greenberg6, A. Monsonego4, D. Turner7, A. Eliakim8, S. Ben Horin8, Y. Chowers9, H. Yanai10, I. Dotan10, S. Odes1

Created: Friday, 22 February 2019, 9:41 AM
P645 Adalimumab drug monitoring is superior to empirical treatment adjustment in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. CURRAIS1, S. Fernandes2, S. Bernardo2, L. Correia2, A.R. Gonçalves2, C. Baldaia2, P. Moura Santos2, A. Valente2, R. Tato Marinho2

Created: Thursday, 30 January 2020, 10:12 AM
P645: Dynamics of proinflammatory cytokines in patients with Crohn's disease who received combined therapy with mesenchymal stromal cells of bone marrow and azathioprine
Year: 2018
Source: ECCO '18 Vienna
Authors:

O. Knyazev, N. Fadeeva*, A. Babayan, E. Dobroluybova, I. Donchenko

Created: Thursday, 21 February 2019, 9:14 AM
P645: Ileocecal resection in paediatric Crohn’s disease based on the Hungarian Paediatric IBD Registry
Year: 2022
Source: ECCO'22
Authors: Müller, K.(1,2);Bajzat, D.(1,3);László, S.S.(4); HUPIR Group
Created: Friday, 11 February 2022, 3:56 PM
P645: Mental health, work presenteeism and exercise in IBD patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Sciberras, M.(1);Nascimento, C.(2);Tabone, T.(1);Karmiris, K.(3);Nikolaou, P.(3);Theodoropoulou, A.(3);Mula, A.(1);Goren, I.(4);Yanai, H.(4);Amir, H.(4);Mantzaris, G.(5);Georgiadi, T.(5);Foteinogiannopoulou, K.(6);Koutroubakis, I.(6);Allocca, M.(7);Fiorino, G.(7);Furfaro, F.(7);Katsanos, K.H.(8);Fousekis, F.(8);Michalopoulos, G.(9);Torres, J.(2);Ellul, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P645: Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Guardiola*1,2, L. Rodriguez Alonso1, N. Padullés3, E. Santacana3, K. Serra1, A. Padulles3, A. Ruiz-Cerulla1, P. Gilabert1, C. Arajol1, G. Ibañez-Sanz1, B. Camps1, H. Colom2, J. Bas4, F. Morandeira4, E. Sanchez1, J. Orobitg1, F. Rodriguez Moranta1

Created: Friday, 22 February 2019, 9:41 AM
P645: The introduction of infliximab therapeutic drug level monitoring for is associated with cost savings in a cohort of patients in a large district general hospital
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Whiteoak S., Johnson H., Hovell C., Weaver S., McLaughlin S.

Created: Wednesday, 20 February 2019, 10:36 AM
P645: Use of Leukocytapheresis in inflammatory bowel disease in paediatric patients. A serie of 10 cases.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Martinez Navarro, G.(1)*;Palomino Pérez, L.M.(1);Velasco Rodríguez-Belvís, M.(1);Cañedo Villarroya, E.(1);De la Mano Hernández, A.(1);Dominguez Ortega, G.(1);Martínez Pérez, J.(1);Martín Fernández, C.(1);Di Campli Zaghlul, M.(1);García Hernández, P.(1);Sánchez Llorente, P.(1);Muñoz Codoceo, R.A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P646 Utilisation of indocyanine green fluorescence imaging for Crohn’s disease following intestinal resection
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Duan, Y. Li

Created: Thursday, 30 January 2020, 10:12 AM
P646: Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Di Ruscio*1, A. Variola1, A. Geccherle1, G. Lunardi2, P. Castelli3, G. Zamboni3, R. Riddell4

Created: Friday, 22 February 2019, 9:41 AM